Position in DXCM
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,884
-$107 QoQ
Shares Held
30
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $5,650,391 across 8 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
35,315 | $3,204,482 | |
| 2 | MDT |
Medtronic plc
|
18,327 | $1,433,720 | |
| 3 | SYK |
Stryker Corp
|
2,668 | $839,992 | |
| 4 | EW |
Edwards Lifesciences Corp
|
1,738 | $157,219 | |
| 5 | BSX |
Boston Scientific Corp
|
184 | $7,853 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
41 | $2,624 | |
| 7 | GMED |
Globus Medical Inc
|
33 | $2,607 | |
| 8 | PEN |
Penumbra Inc
|
6 | $1,894 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,884 | 30 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $1,991 | 30 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,296 | 49 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $4,156 | 62 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,854 | 34 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $554 | 4 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $496 | 4 | Shares | Defined | 2024-02-09 | |
| 2022-06-30 | $2,384 | 32 | Shares | Defined | 2022-08-15 | |
| 2020-12-31 | $33,274 | 90 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||